advocacy

First Opinion By Stanley Plotkin, Norman Baylor, and Keona Jeane Wynne

The U.S. needs a National Vaccine Day

First Opinion By Amir Kalali and Craig Lipset

Decentralized clinical trials: Collaboration is needed to drive their adoption and impact

First Opinion By Nandita Murukutla and Rebecca Perl

Governments’ alcohol subsidies are harmful to public health

First Opinion By Daniel Carpenter and Gregg Gonsalves

The stakes for choosing the right FDA commissioner couldn’t be higher

Politics By Lev Facher

Major health companies and trade groups suspend campaign contributions after Capitol riot

First Opinion By Melissa J. Perry

Stop sidelining science. Bring back federal scientific advisory committees

First Opinion By Vineet Arora, Tricia Pendergrast, and Shikha Jain

Doctors on social media are being cyberbullied and sexually harassed. It’s time to change that

Politics By Lev Facher

Federal judge places restraining order on Trump’s latest drug pricing rule

Politics By Lev Facher

PhRMA took in a record $527 million in 2019, new records show

Politics By Nicholas Florko

Biden’s HHS pick, Becerra, has taken in more campaign cash from health groups than any other industry

First Opinion By David Tuller and Steven Lubet

Proposed British guidelines reject useless chronic fatigue syndrome treatments

First Opinion By Nick Voyles

We can’t eliminate hepatitis C without removing barriers to treatment

First Opinion By Kacie Kidd and Gina Sequeira

Laws to ban gender-affirming care could increase youth suicides, parents fear

Politics By Lev Facher

In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’

Politics By Nicholas Florko

Amid Covid-19, tiny biotech companies are hiring lobbyists for the first time

First Opinion By Gunnar Esiason and Emma D'Agostino

Health care conferences should embrace patients as collaborators

Politics By Lev Facher

AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018

Exclusive By Nicholas Florko

In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies

Politics By Lev Facher

Many drug companies working on Covid-19 vaccines and treatments are lobbying harder than usual

Health By Ruth Hailu

A reckoning for health care professionals: Should they be activists, too?

Politics By Nicholas Florko

PhRMA’s top communicator, a fierce defender of the industry, leaves for ExxonMobil

Exclusive By Nicholas Florko and Matthew Herper

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?

Politics By Lev Facher

General Motors, 3M, and pharma companies beef up lobbying firepower amid coronavirus pandemic

Politics By Nicholas Florko

Congress’s coronavirus stimulus package contains plenty of unrelated wins for the health industry

First Opinion By Sarah Temkin

When surgery becomes ‘women’s work’: the devaluation of gynecologic specialties